The differential diagnosis of a TP53 genetic testing result

被引:1
|
作者
MacFarland, Suzanne P. [1 ,2 ,3 ]
Maxwell, Kara N. [4 ]
机构
[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Perelman Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
关键词
MUTATIONS; OVARIAN; BREAST;
D O I
10.1038/gim.2017.250
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
引用
收藏
页码:806 / 808
页数:3
相关论文
共 50 条
  • [31] TP53 and ovarian cancer
    Schuijer, M
    Berns, EMJJ
    HUMAN MUTATION, 2003, 21 (03) : 285 - 291
  • [32] TP53: an oncogene in disguise
    Soussi, T.
    Wiman, K. G.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (08): : 1239 - 1249
  • [33] TP53 in Myelodysplastic Syndromes
    Jiang, Yan
    Gao, Su-Jun
    Soubise, Benoit
    Douet-Guilbert, Nathalie
    Liu, Zi-Ling
    Troadec, Marie-Berengere
    CANCERS, 2021, 13 (21)
  • [34] THE WAYS OF ACTIVATING TP53
    Polaskova, A.
    Helma, R.
    Adamik, M.
    Hronesova, L.
    Holacka, K.
    Ballova, L.
    Brazdova, M.
    CECE 2014: 11TH INTERNATIONAL INTERDISCIPLINARY MEETING ON BIOANALYSIS, 2014, : 357 - 361
  • [35] TP53: the unluckiest of genes?
    Joerger, Andreas C.
    Stiewe, Thorsten
    Soussi, Thierry
    CELL DEATH AND DIFFERENTIATION, 2025, 32 (02): : 219 - 224
  • [36] TP53 and oesophageal cancer
    Ferec, C
    Giroux, MA
    Audrezet, MP
    Robaszkiewicz, M
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 871 - 875
  • [37] TP53 in urologic tumors
    Algaba, F
    Trias, I
    Santinelli, A
    Montironi, R
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2003, 25 (03): : 123 - 130
  • [38] TP53 and hepatocellular carcinoma
    Puisieux, A
    Ozturk, M
    PATHOLOGIE BIOLOGIE, 1997, 45 (10): : 864 - 870
  • [39] TP53 and breast cancer
    Borresen-Dale, AL
    HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [40] Screening newborns for TP53
    Zlotogora, Joel
    LANCET ONCOLOGY, 2009, 10 (12): : 1142 - 1142